Leadership Team
Søren P. Sheikh MD, PhD, HD
Chief Executive Officer
Søren P. Sheikh has over 35 years of experience in Danish and US universities and hospitals, specializes in gut and neuropeptides, stem cell fate, and differentiation. His research spans molecular signaling mechanisms, transcriptome and proteome profiling, and AI applications in prostate cancer. Søren established the Danish Centre for Regenerative Medicine and the Center for Vascular Regeneration, implementing stem cell treatments in clinical practice. He also led the Department of Clinical Biochemistry & Pharmacology at Odense University Hospital, overseeing 280 employees, including 35 scientists, for 15 years.
Thomas Sandal, MSc, EBA
Chief Development Officer
Thomas Sandal is a biotech leader with 30+ years of experience, specializes in early-stage discovery and CMC development of antibodies and fragments for various indications like RA, ALI, Psoriasis, oncology, and microbiome products. He has held executive positions at PokeAcell, AGC Biologics, Microbiotica Ltd, Crescendo Biologics Ltd, GSK Ltd, and Domantis, advancing numerous compounds to clinical stages. Thomas, a molecular biologist with an engineering degree from the Technical University of Denmark and a Business Administration degree from Copenhagen University College of Engineering, excels in biotech company building and R&D strategy.
Sebastian Wehle, PhD
Chief Operating Officer
Sebastian Wehle, a pharmaceutical executive brings over 20 years of expertise in Manufacturing and Supply, Capital Program Management, and Asset Development. He has a successful track record of launching and supplying one of the first commercial stem cell products, as well as establishing and managing production facilities of various sizes and focus areas. As Chairman on executive-level Program Steering Committees in the past, he has overseen core network expansion strategies, general asset development initiatives, and launch activities.
Board of Directors
Ole Vahlgren
Chairman of the Board
Ole Vahlgren is a 25-years of experience as Senior Pharma Executive, and business development.
Michael Ulveman
Member of the Board
Michael Ulveman is a strategic communication specialist, who is advising companies, organizations and top-executives on communication and public affairs. He has worked for two Danish Prime Ministers and the NATO Secretary General on how to set the agenda in the public and navigate in a complex media environment. With +20 years as journalist, correspondent and editor, Michael has a profound insight in local and international media. Postings include Washington DC and Bruxelles. Today he is the Co-founder and partner in Denmarks leading communication agency, Ulveman & Børsting with a staff of 30 employees.
Anders Vadsholt
Member of the Board
Anders Vadsholt has more than 25 years’ experience from corporate finance, venture capital and the biotech industry. He has recently been CEO and CFO of Orphazyme A/S, which he took public on NASDAQ Copenhagen and NASDAQ New York. Previous experience from Topotarget A/S, BankInvest Biomedical Venture, and Carnegie Investment Bank. Anders holds an MSc in Commercial Law and Economics from Copenhagen Business School and a MBA from Melbourne University.
Sebastian Wehle, PhD
Member of the Board
Sebastian Wehle, a pharmaceutical executive brings over 20 years of expertise in Manufacturing and Supply, Capital Program Management, and Asset Development. He has a successful track record of launching and supplying one of the first commercial stem cell products, as well as establishing and managing production facilities of various sizes and focus areas. As Chairman on executive-level Program Steering Committees in the past, he has overseen core network expansion strategies, general asset development initiatives, and launch activities.
Anella Stelsig Rogaczewski
Member of the Board
Anella Rogaczewski, a seasoned entrepreneur and business advisor, holds a Bachelor's degree in Business and Economics from Copenhagen Business School. With experience in sales and marketing at L'Oréal, Burger King, and Body Shop, she later founded multiple companies across various industries including IT consulting, retail, furniture production, music rights distribution, and interior design. Anella is also educated in board leadership from CBS and joined the Blue Cell board in 2023. Outside her professional endeavors, she actively supports vulnerable children through the NGO Red Barnet.
Blue Cell Team
Benjamin Claass
Senior Scientist
Maja L. Nybo
Senior Scientist
Jone Kvam
Scientist
Mette Søgaard Hansen
Senior Medical Lab Technician
Mingshu M. Eriksen
Senior Lab Technician
Martha Sheikh Chahid
Project Manager
